20^th Global Congress on Biotechnology March 5-7, 2018 Park Inn by Radisson Hotel London, UK

Genome editing and the utilization of CRISPR primarily based technologies are expected to revolutionize the assemblyof the next generation of bioproducts. DCB12 can focus on the most recent developments within the use of CRISPR/Cas9 and alternative CRISPR primarily based technologies in reference to the development and production of biopharmaceuticals, biochemicals, agricultural crops and travel applications.

Pharmaceutical Biotechnology is the science that covers all technologies required for producing, manufacturing and registration of biological drugs. Pharmaceutical Biotechnology is an increasingly important area of science and technology. It contributes in design and delivery of new therapeutic drugs, diagnostic agents for medical tests, and in gene therapy for correcting the medical symptoms of hereditary diseases. The Pharmaceutical Biotechnology is widely spread, ranging from many ethical issues to changes in healthcare practices and a significant contribution to the development of national economy. Biopharmaceuticals consists of large biological molecules which are proteins. They target the underlying mechanisms and pathways of a disease or ailment; it is a relatively young industry. They can deal with targets in humans that are not accessible with traditional medicines.

Bioprocess Engineering combines biotechnology and engineering for the manufacturing of materials from renewable feedstocks.  This field includes fundamental biomolecular research on proteins, enzymes and microbes, as well as work on biosensors, bioseparations and bioreactors.  Applications include food processing and preservation; pharmaceutical, nutraceutical and sweetener production; air and wastewater treatment; bio-based structural motifs for supramolecular architectures; microfluidics for bioreactors and DNA chips; bioenergy; and applications in the pulp and paper industry.  There are natural links to biomedical applications, such as drug metabolism, tissue engineering and bio-based therapeutic treatments.

Medical biotechnology refers to a medicinal or diagnostic product or a vaccine that consists of or has been produced in living organisms and may be manufactured via recombinant. Medical Biotechnology  has a tremendous impact on meeting the needs of patients and their families as it not only encompasses medicines and diagnostics that are manufactured using a biotechnological process, but also gene and cell therapies and tissue engineered products. Today, the majority of innovative medicines, whether manufactured using biotechnology or via a chemical synthesis like a traditional small molecule medicine, as well as many diagnostic products, are made available by applying modern biotechnology in their development and manufacturing.

Systems and Synthetic Biotechnology is a relatively new field in biomedical research. It focuses on engineering new or modified signaling proteins to create desired signaling pathways in the cell. Every living cell is an extremely complex machine expressing thousands of different proteins. Due to superb regulation, many cells, such as photoreceptors and other neurons in vertebrates, can live for decades. Cells can also self-reproduce by division, where both daughter cells are perfectly viable. Natural selection (the “blind watchmaker”, to use Dawkins’ expression) spent hundreds of millions of year to achieve this perfection. Due to elucidation of the intricacies of cellular regulatory mechanisms we can now play evolution on our time scale: re-design proteins and signaling pathways to achieve our ends.Systems and Synthetic Biology is a novel field that finds its origin at the intersection of biology and engineering. It involves designing and construction of biological systems or devices that can be applied in varied domains to get specified results. It’s a multidisciplinary effort made by scientists to understand the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to give specific characteristics to an organism. It can even be used to develop a completely new biological system.

Biotechnology has application in four major industrial areas, including health care (medical), crop production and agriculture, non food (industrial) uses of crops and other products (e.g. biodegradable plastics, vegetable oil, biofuels), and environmental uses.Applied Microbiology and Biotechnology focusses on prokaryotic or eukaryotic cells, relevant enzymes and proteins, applied genetics and molecular biotechnology, genomics and proteomics, applied microbial and cell physiology, environmental biotechnology, process and products and more.

Approximately 120 companies have been identified to be involved in animal biotechnology and are profiled in the report. These are a mix of animal healthcare companies and biotechnology companies. Top companies in this area are identified and ranked. Information is given about the research activities of 11 veterinary and livestock research institutes. Important 108 collaborations in this area are shown.

Biotechnology has been practiced for a long time, as people have sought to improve agriculturally important organisms by selection and breeding. An example of traditional agricultural biotechnology is the development of disease-resistant wheat varieties by cross-breeding different wheat types until the desired disease resistance was present in a resulting new variety. Genetic engineering technologies can help to improve health conditions in less developed countries. Genetic engineering can result in improved keeping properties to make transport of fresh produce easier, giving consumers access to nutritionally valuable whole foods and preventing decay, damage, and loss of nutrients. Benefits of Agriculture Biotechnology include Increased crop productivity, Enhanced crop protection, Improvements in food processing, Improved nutritional value, Environmental benefits, Better flavor, Fresher produce.

Bioenergy is the chemical energy contained in organic matter (biomass) which can be converted into energy forms that we can use directly, such as electricity, heat and liquid fuel.Biomass is any organic matter of recently living plant or animal origin. Unlike coal, the organic matter is not fossilised.Traditionally mainly woody biomass has been used for bioenergy, however more recent technologies have expanded the potential resources to those such as agricultural residues, oilseeds and algae. These advanced bioenergy technologies allow for the sustainable development of the bioenergy industry, without competing with the traditional agricultural industry for land and resources. Bioenergy plants can range from small domestic heating systems to multi-megawatt industrial plants requiring hundreds of thousands of tonnes of biomass fuel each year. A variety of technologies exists to release and use the energy contained in biomass.They range from combustion technologies that are well proven and widely used around the world for generating electricity generation, to emerging technologies that convert biomass into liquid fuels for road, sea and air transport.

Algal biotechnology is a technology developed using algae. The objective of the Micro algal Biotechnology Group is to further the understanding of the ecology of microalgae. This will assist with the development of commercial-scale micro algal culturing techniques for the production of bioactive compounds, aquaculture feed, fine chemicals, and renewable fuels. Additionally, environmental applications such as CO2 bioremediation, control of excessive algal growth and development of management strategies for water supply managers are investigated. Transgenesis in algae is a complex and fast-growing technology. Selectable marker genes, promoters, reporter genes, transformation techniques, and other genetic tools and methods are already available for various species and currently ~25 species are accessible to genetic transformation. Fortunately, large-scale sequencing projects are also planned, in progress, or completed for several of these species.

The  biotechnology that is applied  and used to study the natural environment. Environmental biotechnology could also imply that one try to harness biological process for commercial uses and exploitation. Environmental biotechnology as "the development, use and regulation of biological systems for remediation of contaminated environments  and for environment-friendly processes (green manufacturing technologies and sustainable development). Environmental biotechnology can simply be described as "the optimal use of nature, in the form of plants, animals, bacteria, fungi and algae, to produce renewable energy, food and nutrients in a synergistic integrated cycle of profit making processes where the waste of each process becomes the feedstock for another process".

U.S. sales of environmental  biotechnology products was valued at $241.2 million in 2012. This is expected to increase at a total compound annual growth rate (CAGR) of 7.9%, with 2013 sales of $261.9 million, rising to $382.3 million in 2018.

Nano biotechnology refers to the intersection of nanotechnology and biology. Given that the subject is one that has only emerged very recently, Bio nanotechnology and Nano biotechnology serve as blanket terms for various related technologies. The most important objectives that are frequently found in Nano biology involve applying Nano tools to relevant medical/biological problems and refining these applications. Developing new tools, such as peptoid Nano-sheets, for medical and biological purposes is another primary objective in nanotechnology. New Nano-tools are often made by refining the applications of the Nano-tools that are already being used. The imaging of native biomolecules, biological membranes, and tissues is also a major topic for the Nano-biology researchers. Other topics concerning Nano biology include the use of cantilever array sensors and the application of Nano-photonics for manipulating molecular processes in living cells.